Pages

Tuesday, July 21, 2015

Amgen's Gains EU Approval for Anti-Cholesterol Drug

... later this year. Repatha already has competition. Praluent, a drug developed by Regeneron Pharmaceuticals Inc. in Tarrytown, N.Y., and Paris-based Sanofi, is awaiting regulatory approval.
http://ift.tt/1SAvTb0

No comments:

Post a Comment